Skip to main content
Caplight Logo









Klothea Bio, Inc.

Klothea Bio, Inc.

Private
Miami, FloridaHealthcare & Life Scienceshttps://klothea.com/

Last Round

Seed Round

Sep 8, 2026

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Klothea Bio, Inc. is a biotechnology company developing next-generation longevity therapeutics aimed at delaying age-related diseases by using a proprietary mRNA platform to boost endogenous secretion of the Klotho protein.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

mRNA therapeuticsKlotho protein therapymRNA technologylongevity biotechage-related diseasesclinical stage biotechlipid nanoparticlesLNPsanti-aging biotechhealthspan extensiondrug developmentnanocarrier deliverymetabolic syndromeAlzheimer's diseaseexosomesencapsulated cell therapies

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Klothea Bio, Inc. Comparables

Compare Klothea Bio, Inc. with similar companies based on industry and business-model similarity.

Klothea Bio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rejuvenation Technologies
82%
Jocasta Neuroscience
79%
Turn Biotechnologies
73%

Klothea Bio, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundSep 8, 2026
SeedNov 25, 2024

Key People

Founding team and executive leadership

Olivier Jarry

Chief Operating Officer

Executive Team

Klothea Bio, Inc. Investors

Notable investors and investment history

Klothea Bio, Inc. investors
InvestorRounds
Longevitytech.fundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 8, 2026

    Raised $7M in a seed funding round.

Klothea Bio, Inc. Filings

Explore SEC and related filing metadata, where available.

Klothea Bio, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Klothea Bio, Inc.'s valuation, stock price, and market status.

Is Klothea Bio, Inc. a public or private company?

Klothea Bio, Inc. is a private company.

What is the current stock price of Klothea Bio, Inc.?

Klothea Bio, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Klothea Bio, Inc. worth (valuation)?

Valuation information for Klothea Bio, Inc. is not publicly available.

Can I buy Klothea Bio, Inc. stock?

Klothea Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Klothea Bio, Inc.'s last funding round?

Klothea Bio, Inc.'s most recent funding round was Seed on November 25, 2024.

Who are the main investors in Klothea Bio, Inc.?

Key investors in Klothea Bio, Inc. include Longevitytech.fund.

Will Klothea Bio, Inc. IPO soon?

No public IPO plans have been announced for Klothea Bio, Inc..

How can I track Klothea Bio, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Klothea Bio, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMiami, Florida
Employee Range4
Year Founded2024
Last FundingSep 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?